Accuray reported $100K in Ordinary Share Capital for its fiscal quarter ending in September of 2024.





Ordinary Share Capital Change Date
Abbott USD 1.74B 2.94M Mar/2026
Accuray USD 100K 1000 Sep/2024
AngioDynamics USD 41.57M 127K Sep/2025
Artivion USD 47.84M 468K Dec/2025
AtriCure USD 50.64M 7K Jun/2026
Boston Scientific USD 1.48B 2.66M Dec/2025
Edwards Lifesciences USD 577M 3.7M Mar/2026
Inogen USD 23K 0 Dec/2023
Mesa Laboratories USD 349.53M 3.53M Sep/2024
Orthofix International USD 39.83M 315K Dec/2025
Tandem Diabetes Care USD 68.29M 518K Dec/2025
Trinity Biotech USD 386.76M 1.57M Dec/2025